Article Details

Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With ...

Retrieved on: 2021-04-22 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With .... View article details on HISWAI: https://www.docwirenews.com/abstracts/phase-i-ib-clinical-trial-of-sabatolimab-an-anti-tim-3-antibody-alone-and-in-combination-with-spartalizumab-an-anti-pd-1-antibody-in-advanced-solid-tumors/

Excerpt

PURPOSE: Sabatolimab (MBG453) and spartalizumab are monoclonal antibodies that bind T-cell immunoglobulin domain and mucin domain-3 ...

Article found on: www.docwirenews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up